DV INDEX Trademark

Trademark Overview

On Friday, August 5, 2022, a trademark application was filed for DV INDEX with the United States Patent and Trademark Office. The USPTO has given the DV INDEX trademark a serial number of 97537504. The federal status of this trademark filing is REGISTERED as of Tuesday, April 2, 2024. This trademark is owned by SciMar ONE, Inc.. The DV INDEX trademark is filed in the Advertising, Business and Retail Services category with the following description:

Clinical data analysis for business purposes in the fields of healthcare and pharmaceuticals; Providing business consulting for measurement of efficiency and success metrics for pharmaceutical products from lab to market; Providing a rating system for measurement of efficiency and success metrics for pharmaceutical products from lab to market for business purposes
dv index

General Information

Serial Number97537504
Word MarkDV INDEX
Filing DateFriday, August 5, 2022
Status700 - REGISTERED
Status DateTuesday, April 2, 2024
Registration Number7348345
Registration DateTuesday, April 2, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 21, 2023

Trademark Statements

Goods and ServicesClinical data analysis for business purposes in the fields of healthcare and pharmaceuticals; Providing business consulting for measurement of efficiency and success metrics for pharmaceutical products from lab to market; Providing a rating system for measurement of efficiency and success metrics for pharmaceutical products from lab to market for business purposes
Disclaimer with Predetermined Text"INDEX"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSunday, August 28, 2022
Primary Code035
First Use Anywhere DateMonday, October 31, 2022
First Use In Commerce DateMonday, November 14, 2022

Trademark Owner History

Party NameSciMar ONE, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAllentown, NJ 08501
Party NameSciMar ONE, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAllentown, NJ 08501
Party NameSciMar ONE, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAllentown, NJ 08501

Trademark Events

Event DateEvent Description
Tuesday, April 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 2, 2024REGISTERED-PRINCIPAL REGISTER
Wednesday, February 28, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 27, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, February 24, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 1, 2024USE AMENDMENT FILED
Saturday, February 24, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 1, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, January 16, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 21, 2023PUBLISHED FOR OPPOSITION
Wednesday, November 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, October 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 31, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 31, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, June 3, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, June 3, 2023NON-FINAL ACTION E-MAILED
Saturday, June 3, 2023NON-FINAL ACTION WRITTEN
Tuesday, May 23, 2023ASSIGNED TO EXAMINER
Sunday, August 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 9, 2022NEW APPLICATION ENTERED

Related Keywords

index business pharmaceutical providing measurement products efficiency success from metrics purposes